Menu

Blog

Archive for the ‘biotech/medical’ category: Page 808

Dec 5, 2022

Printable Skin: ‘Inkjet’ Breakthrough Makes Human Tissue

Posted by in categories: biotech/medical, innovation

New technology will allow for custom made skin transplants and possibly make bones and organs, too.

Dec 5, 2022

Reduced brain activity and functional connectivity during creative idea generation in individuals with smartphone addiction

Posted by in categories: biotech/medical, mobile phones, neuroscience

The use of smartphones has become an increasingly popular behaviour in people’s lives. However, an increased number of people find it difficult to minimise the use of smartphones, leading to the emergence of smartphone-addictive behaviours (Panova and Carbonell, 2018; Busch and McCarthy, 2021). In particular, the rapid spread of coronavirus disease 2019 around the world has led to a dramatic increase in the number of smartphone addicts due to home isolation (Caponnetto et al., 2021). Smartphone addiction is an emerging behavioural addiction, which refers to excessive dependence on and abuse of smartphones by individuals (Kwon et al., 2013; Billieux et al., 2015). Notably, smartphone addiction has been reported to have negative impacts on individuals’ cognitive functions, such as attention (Choi et al., 2021; Lee et al., 2021), perception (Dong et al., 2014) and memory (Hartanto and Yang, 2016; Tanil et al., 2020). Nevertheless, the influence of smartphone addiction on individuals’ advanced cognition is still unclear. Smartphone addiction may impair flexible cognitive processes (Dong et al., 2014), such as those that contribute to creative cognition. However, to our knowledge, the influence of smartphone addiction on creative cognition has not been explored.

Given the negative effects and high incidence of smartphone addiction (Zou et al., 2021), it is essential to uncover the underlying mechanisms, especially the neural mechanisms, by which smartphone addiction affects creative cognition. Creative cognition is defined as the ability to generate original and useful products (Sternberg and Lubart, 1999). It is a core cognitive element that allows for daily flexible problem solving and the generation of new ideas. The main components of creative cognition are (i) overcoming the semantic constraints of existing knowledge, which involves goal-directed behaviour through cognitive control, and (ii) building unusual associations to expand the existing structure of knowledge, which involves the spontaneous and unconstrained generation of novel associations (Ward et al., 1997; Abraham, 2014; Marron and Faust, 2019).

According to the problematic mobile phone use model (Billieux et al., 2015), the lack of planning or reduced cognitive control is a crucial contributor to smartphone addiction behaviour. Previous studies have also indicated that impaired cognitive control is a prominent feature of smartphone addicts, characterised by an inability to focus on task-related information and an inability to suppress dominant, automatic responses (Van Deursen et al., 2015; Li et al., 2021). In fact, previous studies have emphasised the contribution of cognitive control to the generation of creative ideas (Beaty et al., 2016; Benedek and Fink, 2019). During creative idea generation, known ideas are often initially retrieved, which acts as a source of interference allowing the retrieval process to focus on familiar and dominant ideas (Abraham, 2014). In this context, cognitive control is needed to drive the retrieval process of novel and remote information.

Dec 5, 2022

Promising New Cancer Therapy Developed by Albert Einstein College of Medicine

Posted by in category: biotech/medical

Immune checkpoints are a normal part of the immune system. Their function is to prevent an immune response from being so powerful that it destroys healthy cells in the body. Immunotherapy drugs called immune checkpoint inhibitors, such as Keytruda and Opdivo, work by unleashing the immune system’s T cells to attack tumor cells. Their introduction a decade ago marked a major advance in cancer therapy. However, only 10% to 30% of treated patients experience long-term improvement.

Now, scientists at Albert Einstein College of Medicine describe findings that could bolster the effectiveness of immune-checkpoint therapy in a study published in The Journal of Clinical Investigation (JCI) on November 15.

Continue reading “Promising New Cancer Therapy Developed by Albert Einstein College of Medicine” »

Dec 5, 2022

Johns Hopkins Researchers Have Identified a Potential New Treatment Target for Sleep Apnea

Posted by in category: biotech/medical

According to Johns Hopkins Medicine scientists, a recent study with obese mice adds to evidence that specialized channel proteins are potential therapeutic targets for sleep apnea and other unusually slow breathing disorders in obese individuals.

The protein, a cation channel known as TRPM7, is located in carotid bodies, minute sensory organs in the neck that sense changes in oxygen and carbon dioxide levels, as well as certain hormones such as leptin, in the bloodstream. TRPM7 proteins aid in the transport and regulation of positively charged molecules into and out of the cells of the carotid bodies.

Lenise Kim, Ph.D., a postdoctoral fellow at Johns Hopkins Medicine and the leader of the current study, expands on earlier results from the lab that indicated TRPM7 had a role in the development of high blood pressure in mice.

Dec 5, 2022

UCSF study shows adults can reduce Alzheimer’s risks with lifestyle changes

Posted by in categories: biotech/medical, neuroscience

SAN FRANCISCO (CBS SF) – At a conference Wednesday afternoon, a UCSF researcher presented the results of a two-year study that found strong evidence that the risk factors for dementia can be reduced up to 30% with a modified lifestyle.

Dr. Kristine Yaffe, a professor of Psychiatry, Neurology, and Epidemiology, presented her findings from a two-year randomized pilot study of nearly 200 older adults at the annual Clinical Trials on Alzheimer’s Disease conference in San Francisco.

She told KPIX 5 that it’s still a complex puzzle as to why some people get Alzheimer’s Disease and others don’t. That’s why her team of researchers joined forces with some colleagues at Kaiser Washington in Seattle and proceeded with the two-year study.

Dec 5, 2022

Spraying an army of bacteria-eating viruses can save us from food poisoning

Posted by in categories: biotech/medical, food

Antibiotics are not enough in the war against pathogens.

Every year more than 40 million people in the U.S. suffer from foodborne illnesses caused by bacteria, viruses, and various other types of pathogens. Food contamination is often underestimated, but it is responsible for 420,000 deaths annually. This number represents more people than the entire population of Iceland.


Urfinguss/iStock.

Continue reading “Spraying an army of bacteria-eating viruses can save us from food poisoning” »

Dec 5, 2022

Researchers discover never-before-seen mechanism bacteria use to resist antibiotic treatment

Posted by in category: biotech/medical

The discovery was made through a fatal bacteria named Group A Streptococcus.

Australian researchers have recently discovered a previously unknown mechanism used by bacteria to resist antibiotic treatment. According to a press release published by Telethon Kids Institute, it’s predicted that this antimicrobial resistance (AMR) will kill ten million people annually by 2050.

Continue reading “Researchers discover never-before-seen mechanism bacteria use to resist antibiotic treatment” »

Dec 5, 2022

A clot too far: An embalmer dissects antivax misinformation about blood clots in Died Suddenly

Posted by in category: biotech/medical

Two weeks ago, COVID-19 conspiracy theorist Stew Peters released an antivax pseudodocumentary, Died Suddenly, whose main claim is that COVID-19 vaccines cause clots that have caused a massive wave of people to “die suddenly.” Key to its narrative are embalmers claiming that they are seeing more clots in the bodies they are embalming than ever before. SBM has recruited Benjamin Schmidt, an experienced embalmer, to dissect their claims.

Dec 5, 2022

Age Reversal

Posted by in categories: biotech/medical, genetics, life extension

A lot of anti-ageing vids lately. Good. This concerns Turn.bio. Though not in this vid, MH does have a habit of asking ‘When?” at some point. Previously Turn.bio said they have a first working treatment in just a few years so we’ll see what happens in vids to come of this interview.


In this video Professor Sebastiano introduces ERA, Epigenetic Reprogramming of Age technology and talks about his thoughts on some of the causes of aging.

Continue reading “Age Reversal” »

Dec 5, 2022

Investing in the Age of Longevity 2022 — Patrick Burgermeister — KIZOO Technology Ventures

Posted by in categories: biotech/medical, business, life extension

Patrick Burgermeister of KIZOO Technology Ventures presents at Investing in the Age of Longevity 2022. In his talk, Patrick gives an overview of KIZOO Technology Ventures’ investment strategy, with a particular focus on misson-driven investments in early stage companies that open new categories of treatment. Patrick showcases six biotech startups that form part of the company’s key investments: Cellvie, Revel, Cyclarity, LIfT BioSciences, Elastrin, and Mogling Bio.

Download the presentation slides: https://bit.ly/IAL22-Patrick-Burgermeister.

Continue reading “Investing in the Age of Longevity 2022 — Patrick Burgermeister — KIZOO Technology Ventures” »

Page 808 of 2,734First805806807808809810811812Last